Walgreens Health Services > Specialty Pharmacy > For payors
For payors
PrintWith more than 800 specialty medications in the pipeline, there is no doubt the impact of these medications will be felt in the years ahead as they become an increasing share of plans’ pharmacy expenditures. According to IMS Health, in 2006, U.S. sales of biotech products alone -- a subset of specialty medications -- reached $40 billion. With a projected annual growth rate of 20 percent in the next few years, sales of specialty medications could top $100 billion by 2010 and represent more than 25 percent of total drug spend.
Our services can help you manage these costly medications while providing optimal patient outcomes, regardless of whether claims are billed under the medical or pharmacy benefit of your health plan. Our partnership will give your members access to:
- Recently approved and limited-distribution specialty medications
- Comprehensive clinical patient support services
- A multi-distribution prescription fulfillment model for greater convenience
- Proven cost savings
- Higher patient and physician satisfaction
For more information:
Email Sue Ewing, Vice President, Managed Care Sales and Contracting